# Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism

**Authors:** Adrienn Horváth, Kitti Tamási, Ramóna Pap, Gergely Jánosa, Edina Pandur

PMC · DOI: 10.3390/nu18010109 · Nutrients · 2025-12-28

## TL;DR

This paper reviews how the body regulates iron levels through various pathways and hormones, focusing on their roles in health and disease.

## Contribution

The paper provides an updated overview of regulatory pathways in iron metabolism and highlights their potential as therapeutic targets.

## Key findings

- Hepcidin is the main regulator of iron homeostasis, influenced by signaling pathways like IL-6/JAK-STAT and BMP/SMAD.
- Iron overload activates pathways that increase hepcidin synthesis, while iron deficiency reduces hepcidin production.
- Regulatory pathways of iron metabolism are potential targets for therapeutic interventions in iron-related disorders.

## Abstract

Iron constitutes an essential micronutrient in living organisms. All iron is absorbed into the body through dietary intake, except for exogenous therapeutic sources. Dietary iron is typically categorized as either heme or nonheme iron. Nonheme iron is essential for regulating iron in the body, as it exists in various forms, including soluble iron, storage iron within ferritin, and iron found in the catalytic centers of a wide range of proteins. Iron homeostasis is carefully managed to ensure that sufficient iron is available for critical biological processes while preventing the harmful effects that can arise from excess iron. The small peptide hormone hepcidin is the main regulator of iron homeostasis. Hepcidin and other iron regulatory molecules are regulated by various signaling pathways, such as IL-6/JAK-STAT, BMP/SMAD, and MAPK. Alterations in regulatory pathways may occur in response to iron accumulation or deficiency. Iron overload in the body can activate JAK/STAT, BMP/SMAD and MAPK pathways, leading to the initiation hepcidin synthesis. Conversely, in iron deficiency, as in hypoxic conditions or EPO-mediated signaling pathways, HAMP synthesis in the nucleus is reduced. Thus, this review provides an update on the possible regulatory pathways that play a role in iron regulation and may be potential therapeutic targets.

## Linked entities

- **Proteins:** HAMP (hepcidin antimicrobial peptide), ferritin (soma ferritin-like), IL6 (interleukin 6), jak (Janus kinase), SOAT1 (sterol O-acyltransferase 1), dpp (decapentaplegic), Smox (Smad on X), MAPK (mitogen activated kinase-like protein), EPO (erythropoietin), HAMP (hepcidin antimicrobial peptide)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, HAMP (hepcidin antimicrobial peptide) [NCBI Gene 57817] {aka HEPC, HFE2B, LEAP1, PLTR}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}
- **Diseases:** Iron overload (MESH:D019190), iron deficiency (MESH:D000090463), hypoxic (MESH:D002534)
- **Chemicals:** heme (MESH:D006418), Iron (MESH:D007501)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12787992/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12787992/full.md

## References

192 references — full list in the complete paper: https://tomesphere.com/paper/PMC12787992/full.md

---
Source: https://tomesphere.com/paper/PMC12787992